An insulin management system made by Acton medical device company Insulet is now available in Canada, the company announced on Monday.
“The Omnipod DASH System’s sleek, touchscreen Personal Diabetes Manager (PDM), combined with the existing benefits of Pod therapy, will provide Canadian users even more freedom, flexibility, and discretion to simplify their diabetes management,” said Chief Commercial Officer Bret Christensen, in a statement.
The Omnipod DASH System combines a tubeless, wearable waterproof pod with a touchscreen PDM. The pod, according to Insulet, allows up to 72 hours of continuous insulin therapy, allowing its users to live their lives without needing to inject insulin daily.